Tasso Announces $100M Series B Round

▤ Summary

SEATTLE, WA, Tasso today announced that it has completed an oversubscribed $100 million Series B financing round. The financing round was led by RA Capital Management and included participation from new investors the D.E. Shaw group, Senvest, InCube, and SVB Innovation Fund, as well as existing investors Foresite Capital, Hambrecht Ducera Growth Ventures, J2V, Cedars-Sinai, and Merck GHIF. Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The companys devices enable simple, convenient, and virtually painless blood collection for users.

▦ Linked Companies